RESEARCH
Year : 2007  |  Volume : 6  |  Issue : 1  |  Page : 11

α2β1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis


1 Gynaecological Cancer Research Centre, Royal Women's Hospital; 2Centre for Cellular and Molecular Biology, Deakin University; Translational Proteomics, Baker Heart Research Institute, Melbourne, Australia
2 Gynaecological Cancer Research Centre, Royal Women's Hospital; Translational Proteomics, Baker Heart Research Institute, Melbourne, Australia
3 Gynaecological Cancer Research Centre, Royal Women's Hospital; Department of Obstetrics and Gynaecology, University of Melbourne, Australia
4 Centre for Cellular and Molecular Biology, Deakin University, Melbourne, Australia
5 Gynaecological Cancer Research Centre, Royal Women's Hospital; Translational Proteomics, Baker Heart Research Institute; Department of Obstetrics and Gynaecology, University of Melbourne; Department of Surgery, University of Melbourne, Australia

Correspondence Address:
Nuzhat Ahmed
Gynaecological Cancer Research Centre, Royal Women's Hospital; Translational Proteomics, Baker Heart Research Institute; Department of Obstetrics and Gynaecology, University of Melbourne; Department of Surgery, University of Melbourne
Australia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.1186/1477-3163-6-11

Background Ovarian cancer is characterized by a wide-spread intra-abdominal metastases which represents a major clinical hurdle in the prognosis and management of the disease. A significant proportion of ovarian cancer cells in peritoneal ascites exist as multicellular aggregates or spheroids. We hypothesize that these cellular aggregates or spheroids are invasive with the capacity to survive and implant on the peritoneal surface. This study was designed to elucidate early inherent mechanism(s) of spheroid survival, growth and disaggregation required for peritoneal metastases Methods In this study, we determined the growth pattern and adhesive capacity of ovarian cancer cell lines (HEY and OVHS1) grown as spheroids, using the well established liquid overlay technique, and compared them to a normal ovarian cell line (IOSE29) and cancer cells grown as a monolayer. The proteolytic capacity of these spheroids was compared with cells grown as a monolayer using a gelatin zymography assay to analyze secreted MMP-2/9 in conditioned serum-free medium. The disaggregation of cancer cell line spheroids was determined on extracellular matrices (ECM) such as laminin (LM), fibronectin (FN) and collagen (CI) and the expression of α2, α3, αv, α6 and β1 interin was determined by flow cytometric analysis. Neutralizing antibodies against α2, β1 subunits and α2β1 integrin was used to inhibit disaggregation as well as activation of MMPs in spheroids. Results We demonstrate that ovarian cancer cell lines grown as spheroids can sustain growth for 10 days while the normal ovarian cell line failed to grow beyond 2 days. Compared to cells grown as a monolayer, cancer cells grown as spheroids demonstrated no change in adhesion for up to 4 days, while IOSE29 cells had a 2-4-fold loss of adhesion within 2 days. Cancer cell spheroids disaggregated on extracellular matrices (ECM) and demonstrated enhanced expression of secreted pro-MMP2 as well as activated MMP2/MMP9 with no such activation of MMP's observed in monolayer cells. Flow cytometric analysis demonstrated enhanced expression of α2 and diminution of α6 integrin subunits in spheroids versus monolayer cells. No change in the expression of α3, αv and β1 subunits was evident. Conversely, except for αv integrin, a 1.5-7.5-fold decrease in α2, α3, α6 and β1 integrin subunit expression was observed in IOSE29 cells within 2 days. Neutralizing antibodies against α2, β1 subunits and α2β1 integrin inhibited disaggregation as well as activation of MMPs in spheroids. Conclusion Our results suggest that enhanced expression of α2β1 integrin may influence spheroid disaggregation and proteolysis responsible for the peritoneal dissemination of ovarian carcinoma. This may indicate a new therapeutic target for the suppression of the peritoneal metastasis associated with advanced ovarian carcinomas.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed7696    
    Printed269    
    Emailed0    
    PDF Downloaded747    
    Comments [Add]    
    Cited by others 48    

Recommend this journal